Business Context and Reporting Period
P3 Health Partners Inc. filed this Form 8-K on February 11, 2026, reporting the entry into a material definitive agreement. The filing concerns P3 Health Group, LLC, a subsidiary of the registrant.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or overall liquidity metrics. The only specific financial figure disclosed relates to a debt instrument:
- Debt Availability: $19.0 million remaining from the third tranche of an Unsecured Promissory Note.
Material Changes
The Company amended an Unsecured Promissory Note originally dated May 29, 2025, with VBC Growth SPV 5, LLC. The amendment extends the availability period for the remaining $19.0 million of the third tranche, allowing for one or more draws through June 30, 2026. All other terms of the Note remain unchanged.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks beyond the specific terms of the amended note. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the full terms of the Amendment to the Unsecured Promissory Note in Exhibit 10.1.
- Confirm the total outstanding balance of the Note and the status of previous tranches.
- Review the Company's liquidity position to assess the necessity of drawing the remaining $19.0 million.